KURAKura Oncology, Inc.

$774M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$10,000

Operating Income

-$63M

Net Income

-$60M

EPS (Diluted)

$-1.72

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$49M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$182M

Total Liabilities

$21M

Stockholders' Equity

$161M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$10,000	-$30,000	+66.7%
Operating Income	-$63M	-$36M	-74.3%
Net Income	-$60M	-$35M	-70.6%

KURA FY 2018 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena